title: The molecular pharmacology of doxorubicin in vivo.
authors.affiliation: Imperial Cancer Research Fund, Western General Hospital, Edinburgh, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Cummings
authors.forename: L
authors.initials: L
authors.lastname: Anderson
authors.forename: N
authors.initials: N
authors.lastname: Willmott
authors.forename: J F
authors.initials: JF
authors.lastname: Smyth
mesh_terms: D001665:Binding Sites; D002462:Cell Membrane / Q000378:metabolism; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004273:DNA, Neoplasm / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology* / Q000627:therapeutic use; D004798:Enzymes / Q000378:metabolism; D005609:Free Radicals; D006801:Humans; D009369:Neoplasms / Q000201:enzymology
chemical_list: D004273:DNA, Neoplasm; D004798:Enzymes; D005609:Free Radicals; D004317:Doxorubicin; D004250:DNA Topoisomerases, Type II